No Data
No Data
Elicio Therapeutics Hires CFO From Cidara Therapeutics
Wall Street Analysts Predict a 64.5% Upside in Cidara Therapeutics (CDTX): Here's What You Should Know
Cidara Therapeutics Announces Participation In WHO Panel On H5N1 Influenza Preparedness And Response, Discussing Pharmaceuticals As Preventive Tools On March 19, 2025
JMP Securities Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $46
Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response
Cidara Therapeutics to Present on CD388 at ICAR 2025